全文获取类型
收费全文 | 99499篇 |
免费 | 8845篇 |
国内免费 | 5975篇 |
专业分类
耳鼻咽喉 | 1016篇 |
儿科学 | 1365篇 |
妇产科学 | 607篇 |
基础医学 | 8903篇 |
口腔科学 | 1546篇 |
临床医学 | 10825篇 |
内科学 | 10823篇 |
皮肤病学 | 1165篇 |
神经病学 | 3390篇 |
特种医学 | 4484篇 |
外国民族医学 | 8篇 |
外科学 | 11901篇 |
综合类 | 22730篇 |
现状与发展 | 25篇 |
一般理论 | 3篇 |
预防医学 | 9306篇 |
眼科学 | 1568篇 |
药学 | 10749篇 |
101篇 | |
中国医学 | 7437篇 |
肿瘤学 | 6367篇 |
出版年
2024年 | 332篇 |
2023年 | 1059篇 |
2022年 | 2818篇 |
2021年 | 3755篇 |
2020年 | 3084篇 |
2019年 | 2246篇 |
2018年 | 2399篇 |
2017年 | 2720篇 |
2016年 | 2485篇 |
2015年 | 4140篇 |
2014年 | 5349篇 |
2013年 | 6163篇 |
2012年 | 8913篇 |
2011年 | 9309篇 |
2010年 | 7751篇 |
2009年 | 6792篇 |
2008年 | 7393篇 |
2007年 | 7092篇 |
2006年 | 6477篇 |
2005年 | 5366篇 |
2004年 | 4011篇 |
2003年 | 3779篇 |
2002年 | 3271篇 |
2001年 | 2504篇 |
2000年 | 1672篇 |
1999年 | 911篇 |
1998年 | 443篇 |
1997年 | 436篇 |
1996年 | 322篇 |
1995年 | 253篇 |
1994年 | 205篇 |
1993年 | 120篇 |
1992年 | 118篇 |
1991年 | 115篇 |
1990年 | 74篇 |
1989年 | 66篇 |
1988年 | 54篇 |
1987年 | 54篇 |
1986年 | 43篇 |
1985年 | 36篇 |
1984年 | 14篇 |
1983年 | 20篇 |
1982年 | 19篇 |
1980年 | 9篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1975年 | 8篇 |
1974年 | 9篇 |
1973年 | 8篇 |
1957年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目前新型冠状病毒肺炎(COVID-19)疫情在全球蔓延,形势严峻,并对全球公共卫生事业构成巨大挑战,快速准确的诊断COVID-19对疫情的防控有重要意义。本文报道1例COVID-19患者的调查和确诊过程,以对COVID-19确诊和疫情防控提供有价值的参考。患者为赴渝务工于2020年1月23日返乡人员,在渝期间,其同工地的一同事确诊为COVID-19,之后该工地接连有另外8位同事被确诊。患者返乡后2月2日被当地疫情防控单位采取医学隔离。患者于隔离后不久出现咳嗽,阵发性,干咳为主,偶可咳出黄色痰液等COVID-19相关临床症状,遂被当地新型冠状病毒肺炎定点医疗单位收治,后经市级新型冠状病毒肺炎诊治专家组远程视频会诊转入四川大学华西医院资阳医院。患者先后经历9次核酸检测,在前8次核酸检测均为阴性的情况下,于第9次核酸检测结果为阳性,2月21日最终确诊为新型冠状病毒肺炎。 相似文献
3.
毛细胞白血病(HCL)是一种以脾大、全血细胞减少、骨髓组织增生等为临床表现的罕见慢性B淋巴细胞增殖性疾病。克拉屈滨作为其一线药物,对HCL的完全缓解率很高。本文报道了2017-09-04绍兴市人民医院收治的1例经典型HCL患者在克拉屈滨治疗期间,出现严重粒细胞缺乏伴高热,合并全身皮疹及间质性肺炎,经大剂量激素等治疗后好转的诊疗过程。并结合文献回顾了HCL的诊断及治疗方法,简述了克拉屈滨治疗HCL致间质性肺炎这一少见并发症的诊疗思路,以提高临床医师对该毒副作用的认识,为临床工作提供帮助。 相似文献
4.
Jae Hwang Song Chan Kang Deuk Soo Hwang Dong Hun Kang Yong Hwan Kim 《Foot and Ankle Surgery》2019,25(6):748-754
BackgroundThe purpose of this study was to investigate and compare the clinical outcomes of dorsal suspension with those of neurectomy for the treatment of Morton’s neuroma.MethodsWe conducted a retrospective study of dorsal suspension and neurectomy group. The dorsal suspension was performed by dorsal transposition of neuroma over the dorsal transverse ligament after neurolysis. The visual analog scale (VAS), the Foot and Ankle Ability Measure (FAAM), postoperative satisfaction, and complications were evaluated.ResultsBoth groups reported significant pain relief, and there were no significant differences between the groups with respect to postoperative pain. The postoperative FAAM outcomes showed no significant between-group differences. Satisfaction analysis showed ‘excellent’ and ‘good’ results in the dorsal suspension and neurectomy groups (95% and 77.7%, respectively). Complications of numbness and paresthesia reported in the dorsal suspension group (5% and 5%, respectively) were significantly fewer than those of neurectomy group (61.1% and 33.3%, respectively) (both, p < .05).ConclusionsWith its favorable results, dorsal suspension can be another operative option for the treatment of Morton’s neuroma.Level of Evidence: Level III, retrospective comparative case series. 相似文献
5.
6.
Tian-Yuan Xiong Fang-Yang Huang Qi Liu Yong Peng Yuan-Ning Xu Jia-Fu Wei 《Annals of medicine》2020,52(7):361-366
Abstract
Background
Comorbidities are commonly seen in patients with coronavirus disease 2019 (COVID-19), but the clinical implication is not yet well-delineated. We aim to characterize the prevalence and clinical implications of comorbidities in patients with COVID-19. 相似文献7.
Xue Yao Yan Zhang Jian Hao Hui-Quan Duan Chen-Xi Zhao Chao Sun Bo Li Bao-You Fan Xu Wang Wen-Xiang Li Xuan-Hao Fu Yong Hu Chang Liu Xiao-Hong Kong Shi-Qing Feng 《中国神经再生研究》2019,(3)
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury. 相似文献
8.
9.
10.